JFL LIFE SCIENCES LIMITED Fair Value
JFLLIFE · Healthcare · Current price ₹10.55
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹14 | 11% ROE fading to 13% over ~3 yrs, on ₹14 book |
| Relative P/E | ₹29 | EPS × 30.3 peer-median P/E |
| Graham floor | ₹17 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is JFL LIFE SCIENCES LIMITED undervalued?
DocStoX estimates the fair value of JFL LIFE SCIENCES LIMITED at ₹19 per share, versus the current market price of ₹11. That puts the stock about +77.1% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹14), Relative P/E (₹29), Graham floor (₹17). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹14 (bear) to ₹19 (base) to ₹29 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on JFL LIFE SCIENCES LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.